Opinion
Video
Precision Medicine in Breast Cancer: Evolving Paradigms in HER2 Testing and Clinical Implications
Author(s):
Panelists discuss how evolving HER2 classification methods and recent trial data are reshaping treatment approaches for advanced breast cancer, particularly regarding the clinical significance of HER2-low and ultralow categories.
Video content above is prompted by the following:
- Briefly discuss the recent updates in assessing HER2-positive status in advanced breast cancer.
- How do you currently define HER2-low and HER2-ultralow status, and what are some associated challenges?
- What insights do recent clinical trial findings from DESTINY-Breast06 provide, and how may these findings impact the practice setting?
Related Videos
Related Content
